Legal & General Group
CRBU icon

Legal & General Group’s Caribou Biosciences CRBU Stock Holding History

Legal & General Group’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,941
Closed -$6.34K – 3443
2025
Q1 		$6.34K Hold
6,941
– – ﹤0.01% 3246
2024
Q4 		$11K Hold
6,941
– – ﹤0.01% 3235
2024
Q3 		$13.6K Hold
6,941
– – ﹤0.01% 3194
2024
Q2 		$11.4K Hold
6,941
– – ﹤0.01% 3268
2024
Q1 		$35.7K Hold
6,941
– – ﹤0.01% 2823
2023
Q4 		$39.8K Buy
6,941
+747
+12% +$3.69K ﹤0.01% 2838
2023
Q3 		$29.6K Buy
6,194
+684
+12% +$4.24K ﹤0.01% 2924
2023
Q2 		$23.4K Sell
5,510
-2,249
-29% -$10.1K ﹤0.01% 3049
2023
Q1 		$41.2K Sell
7,759
-10,437
-57% -$65K ﹤0.01% 2911
2022
Q4 		$114K Buy
18,196
+429
+2% +$3.82K ﹤0.01% 2790
2022
Q3 		$188K Buy
17,767
+1,294
+8% +$12.1K ﹤0.01% 2655
2022
Q2 		$89K Buy
16,473
+5,240
+47% +$40.1K ﹤0.01% 2885
2022
Q1 		$103K Buy
11,233
+3,080
+38% +$32.5K ﹤0.01% 2856
2021
Q4 		$123K Buy
8,153
+6,355
+353% +$124K ﹤0.01% 2866
2021
Q3 		$43K Buy
+1,798
New +$44K ﹤0.01% 3017

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legal & General Group's CRBU Position: Q2 2025 in Review

Legal & General Group sold out of Caribou Biosciences (CRBU) in Q2 2025, closing a stake of 6,941 shares — an estimated $6.34K sold.

Legal & General Group first reported a position in CRBU in Q3 2021 and held it in 15 quarters. The position peaked at $188K in Q3 2022. 129 funds tracked by Wall St. Rank hold CRBU as of Q2 2025.

  • Legal & General Group reported no remaining Caribou Biosciences position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 6,941 Caribou Biosciences shares in Q2 2025, an estimated $6.34K.
  • Legal & General Group first reported a position in Caribou Biosciences in Q3 2021 and held it in 15 quarters.
  • Legal & General Group's Caribou Biosciences position peaked at $188K in Q3 2022.
  • 129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.